moxalactam has been researched along with Central Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, GS; Brogden, RN; Carmine, AA; Heel, RC; Romankiewicz, JA; Speight, TM | 1 |
1 review(s) available for moxalactam and Central Nervous System Diseases
| Article | Year |
|---|---|
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Absorption; Adult; Aminoglycosides; Bacteria, Anaerobic; Central Nervous System Diseases; Child; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Infant, Newborn; Inflammation; Kidney Diseases; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Sepsis; Staphylococcus; Streptococcus; Tissue Distribution; Urinary Tract Infections | 1983 |